Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know?

被引：6
|
作者：
Hadda, Vijay [1 ]
Guleria, Randeep [1 ]
机构：
[1] All India Inst Med Sci, Dept Pulm Crit Care & Sleep Med, New Delhi 110029, India
来源：
INDIAN JOURNAL OF MEDICAL RESEARCH | 2020年 / 152卷 / 03期
关键词：
PIRFENIDONE; NINTEDANIB; EFFICACY; UPDATE; TRIAL;
D O I：
10.4103/ijmr.IJMR_90_20
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：177 / 180
页数：4
相关论文
共 50 条
  • [21] Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
    Keishi Sugino
    Hirotaka Ono
    Natsumi Watanabe
    Masahiro Ando
    Eiyasu Tsuboi
    Sakae Homma
    Kazuma Kishi
    [J]. BMC Pulmonary Medicine, 21
  • [22] Comorbidities influence in idiopathic pulmonary fibrosis antifibrotic treatments
    Nieto Barbero, Ma Asuncion
    Javier Gonzalez-Gamiz, Francisco
    Jesus Rodriguez-Nieto, Ma
    Sanchez, Susana
    Gaudo, Javier
    Valenzuela, Claudia
    Lopez-Muniz, Belen
    Gomez-Carrera, Luis
    Laporta, Rosalia
    Casanova, Alvaro
    Teresa Rio, Maria
    Neumomadrid, Refipimad
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [23] Pattern of Utilization for Antifibrotic Therapy in Idiopathic Pulmonary Fibrosis
    Sedarati, K.
    Gordon, J. A.
    Graham, W. B.
    Sridhar, S.
    Rawal, N.
    Mohajer, K.
    Knowles, N.
    Wei, K.
    Patino, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [24] Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
    Sugino, Keishi
    Ono, Hirotaka
    Watanabe, Natsumi
    Ando, Masahiro
    Tsuboi, Eiyasu
    Homma, Sakae
    Kishi, Kazuma
    [J]. BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [25] Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
    Toby M. Maher
    Mary E. Strek
    [J]. Respiratory Research, 20
  • [26] EFFICACY AND SAFETY OF ANTIFIBROTIC AGENTS IN IDIOPATHIC PULMONARY FIBROSIS
    Nunez-Garcia, L.
    Valenzuela, C.
    Alonso, T.
    Vicente, E. F.
    Ancochea, J.
    Castaneda, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 759 - 760
  • [27] Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis
    Dempsey, Timothy M.
    Sangaralingham, Lindsey R.
    Yao, Xiaoxi
    Sanghavi, Darshak
    Shah, Nilay D.
    Limper, Andrew H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (02) : 168 - 174
  • [28] Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
    Maher, Toby M.
    Strek, Mary E.
    [J]. RESPIRATORY RESEARCH, 2019, 20 (01)
  • [29] Idiopathic pulmonary fibrosis: What primary care physicians need to know
    Tolle, Leslie B.
    Southern, Brian D.
    Culver, Daniel A.
    Horowitz, Jeffrey C.
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2018, 85 (05) : 377 - 386
  • [30] Adherence and Persistence to Antifibrotic Treatments for Idiopathic Pulmonary Fibrosis
    Raimundo, Karina
    Kong, Amanda
    Gray, Stephani
    Benloucif, Slim
    Limb, Susan
    [J]. CHEST, 2017, 152 (04) : 441A - 441A
12345